Rabies Vaccine in Pregnant Women
The inactivated rabies vaccine is both safe and strongly indicated for pregnant women following potential rabies exposure, and pregnancy should never be considered a contraindication to post-exposure prophylaxis given rabies' near-100% fatality rate. 1, 2
Post-Exposure Prophylaxis (PEP): Mandatory and Safe
For pregnant women exposed to potentially rabid animals, rabies PEP must be administered immediately without delay. The evidence is unequivocal:
- No increased risk of adverse pregnancy outcomes has been documented following post-exposure rabies vaccination compared to background rates 1
- The FDA drug label explicitly states that pregnancy is not a contraindication to post-exposure prophylaxis because the potential consequences of inadequately treated rabies exposure far outweigh any theoretical risks 2
- A large prospective study of 202 pregnant Thai women who received tissue culture-derived rabies vaccine and rabies immune globulin showed adverse reaction rates similar to non-pregnant patients, with no fetal harm 3
The Clinical Algorithm for PEP in Pregnancy:
- Administer immediately upon exposure assessment—do not delay for pregnancy considerations
- Standard regimen applies: 4-dose vaccine series (days 0,3,7,14) plus rabies immune globulin (RIG) infiltrated around the wound 4, 2
- Injection site: Deltoid muscle in adults; anterolateral thigh acceptable in pregnancy if preferred 2
- RIG is safe: Both human (HRIG) and equine (ERIG) rabies immune globulin have been used safely in pregnancy 3
Pre-Exposure Prophylaxis (PrEP): Indicated for High-Risk Pregnant Women
Pre-exposure vaccination should be offered to pregnant women at substantial risk of rabies exposure, such as veterinarians, animal handlers, laboratory workers, or travelers to rabies-endemic areas 1, 2.
The rationale is straightforward:
- Safety data from post-exposure studies support pre-exposure use 1
- The 3-dose series (days 0,7,21 or 28) has been administered safely during pregnancy 5
- A study of 29 pregnant women receiving PVRV showed no adverse effects, normal fetal development, no congenital anomalies, and adequate antibody responses well above protective levels (>0.5 IU/ml) 5
Safety Evidence Across Trimesters
The evidence demonstrates safety throughout pregnancy:
- All trimesters: Studies included women in first, second, and third trimesters with uniformly good outcomes 6, 5
- Delivery outcomes: Both vaginal and cesarean deliveries were safe; infants were healthy with normal growth and development 7, 5
- Antibody transfer: Protective antibody levels transfer to newborns, providing passive immunity (though levels may be suboptimal if delivery occurs within 5 days of maternal vaccination) 6
Critical Pitfalls to Avoid
- Never delay or withhold rabies PEP due to pregnancy—this is the most dangerous error given rabies' lethality 1, 2
- Do not administer vaccine in the gluteal area—this has been associated with vaccine failures; use deltoid muscle 8, 9
- Ensure adequate wound cleansing with soap and water before vaccination 8
- Infiltrate RIG around the wound site—failure to do so has been linked to prophylaxis failures 8, 9
Lactation Considerations
Rabies vaccination is safe during breastfeeding. While it's unknown whether the vaccine is excreted in breast milk, the inactivated virus poses no theoretical risk, and the benefits of preventing maternal rabies far outweigh any concerns 2, 10.
The Bottom Line
The 2022 American Journal of Obstetrics and Gynecology guidelines provide the most current framework: Given rabies' high case fatality rate, pregnancy is not a contraindication to post-exposure prophylaxis and may be considered for pre-exposure prophylaxis in at-risk women 1. This recommendation is reinforced by FDA labeling 2 and supported by multiple clinical studies showing safety and efficacy 6, 7, 5, 3.
The decision algorithm is simple: If exposed or at high risk → vaccinate immediately, regardless of pregnancy status.